North American Contact Dermatitis Group Patch Test Results: 2019–2020
Dermatitis® · 01.03.2023 · 34 (2) · 90-104
DOI: 10.1089/derm.2022.29017.jdk ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatitis®, online erschienen am 16.03.2023. Verfasst von Joel G DeKoven und 17 weiteren Autor:innen. Beteiligte Einrichtung: From the *Division of Dermatology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada. Hauptthemen laut MEDLINE: Dermatitis, Allergic Contact. Die Arbeit wurde bisher 131-mal zitiert (Crossref) und nennt 54 Literaturangaben.
Abstract (Originalsprache)
Background
Patch testing is an important diagnostic tool for assessment of allergic contact dermatitis (ACD).
Objective
This study documents the North American Contact Dermatitis Group (NACDG) patch testing results from January 1, 2019, to December 31, 2020.
Methods
At 13 centers in North America, patients were tested in a standardized manner with a screening series of 80 allergens, and, as indicated, supplemental allergens.
Results
Overall, 4121 patients were tested; 2871 (69.7%) had at least 1 positive/allergic patch test reaction and 2095 patients (51.2%) had a primary diagnosis of ACD. The most commonly positive allergens were nickel (18.2%), methylisothiazolinone (MI) (13.8%), fragrance mix (FM) I (12.8%), hydroperoxides of linalool (HPL) (11.1%), and benzisothiazolinone (BIT) (10.4%). Compared with that of 2017–2018, prevalence of top 20 allergens statistically increased for FM I, HPL, BIT, propolis, and hydroperoxides of limonene (3.5%). For the first time, MI positivity did not increase between reporting periods. Approximately one-fifth of patients (20.3%) had ≥1 clinically relevant reaction(s) to allergens/substances not on the NACDG series.
Conclusions
The epidemic of MI contact allergy in North America may have reached a plateau. Patch testing using a robust screening series, and supplemental allergens as indicated, is necessary for comprehensive evaluation of ACD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the *Division of Dermatology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
- Division of Occupational Health, Unity Health Toronto, St. Michael's Hospital, Toronto, Canada.
- Department of Dermatology, Park Nicollet/Health Partners Health Services, Minneapolis, Minnesota, USA.
- Department of Dermatology, University of Minnesota, Minneapolis, Minnesota, USA.
- Department of Dermatology, Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota, USA.
- Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Zitieren
APA
DeKoven, J. G., Warshaw, E. M., Reeder, M. J., Atwater, A. R., Silverberg, J. I., Belsito, D. V., Sasseville, D., Zug, K. A., Taylor, J. S., Pratt, M. D., Maibach, H. I., Fowler, J. F., Adler, B. L., Houle, M. C., Mowad, C. M., Botto, N., Yu, J., & Dunnick, C. A. (2023). North American Contact Dermatitis Group Patch Test Results: 2019–2020. Dermatitis®, 34(2), 90-104. https://doi.org/10.1089/derm.2022.29017.jdk
Vancouver
DeKoven JG, Warshaw EM, Reeder MJ, Atwater AR, Silverberg JI, Belsito DV, et al. North American Contact Dermatitis Group Patch Test Results: 2019–2020. Dermatitis®. 2023;34(2):90-104. doi:10.1089/derm.2022.29017.jdk
BibTeX
@article{DeKoven2023,
author = {DeKoven, Joel G and Warshaw, Erin M and Reeder, Margo J and Atwater, Amber R and Silverberg, Jonathan I and Belsito, Donald V and Sasseville, Denis and Zug, Kathryn A and Taylor, James S and Pratt, Melanie D and Maibach, Howard I and Fowler, Joseph F and Adler, Brandon L and Houle, Marie-Claude and Mowad, Christen M and Botto, Nina and Yu, JiaDe and Dunnick, Cory A},
title = {North American Contact Dermatitis Group Patch Test Results: 2019–2020},
journal = {Dermatitis®},
year = {2023},
volume = {34},
number = {2},
pages = {90--104},
doi = {10.1089/derm.2022.29017.jdk}
}
EUVIMED